SS Innovations International
SSII
2.67
-0.07
-2.55%
SS Innovations International
US · SSII
#3689 by market cap
2.67
-0.07
-2.55%
Live - 5344 symbols - heartbeat 482s ago
· 2026-10-08 10:00
Pre-market
2.56
-6.74%
After-hours
2.74
0.00%
Overnight
2.77
+1.09%
- Market cap
- 534.00M
- P/E (TTM)i
- -44.50
- P/Bi
- 10.00
- EPSi
- -0.06
- Div yieldi
- 0.00%
- 52W posi
- 1%
Reader sentiment
Are you bullish or bearish on SSII?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 8.42, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +105.74% YoY
Margins
- Gross margin
- 46.00%
- Operating margin
- -19.29%
- Net margin
- -28.55%
Key ratios & quality
- Altman Z-Scorei
- 8.42
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 1.44M | -- | 20.65M | 42.48M |
| Gross profit | -- | -- | -- | -- | 60.58K | 725.53K | 8.45M | 19.54M |
| Selling & admin expenses | 933.26K | 3.26M | 1.10M | 1.41M | 1.94M | 19.79M | 24.50M | 22.98M |
| Research & development | 27.13K | 60.87K | 3.00K | 1.00K | 987.44K | 1.06M | 2.49M | 3.69M |
| Operating profit | -960.38K | -3.32M | -1.10M | -1.41M | -2.96M | -20.27M | -18.98M | -8.19M |
| Pretax profit | -960.32K | -3.39M | -1.12M | -1.48M | -3.21M | -20.88M | -19.15M | -8.16M |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.97M |
| Net profit | -960.32K | -3.39M | -1.12M | -1.48M | -3.21M | -20.88M | -19.15M | -12.13M |
| Basic EPS | -1 | -2 | -1 | -1 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.50 | -1.60 | -0.50 | -0.50 | -0.03 | -0.14 | -0.11 | -0.06 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 5.12M | 10.00M | 12.83M | 14.53M | 11.10M | 13.94M |
| Gross profit | 1.09M | 5.92M | 6.16M | 6.38M | 5.33M | 7.10M |
| Selling & admin expenses | 5.79M | 5.06M | 6.92M | 5.41M | 7.65M | 6.63M |
| Research & development | 1.01M | 498.60K | 786.32K | 1.39M | 995.44K | 2.40M |
| Operating profit | -5.92M | 97.01K | -1.84M | -735.00K | -3.64M | -2.27M |
| Pretax profit | -5.68M | 97.04K | -1.87M | -705.73K | -3.43M | -2.16M |
| Tax | 0 | 353.73K | 1.85M | 1.77M | 151.35K | 505.28K |
| Net profit | -5.68M | -256.69K | -3.72M | -2.47M | -3.58M | -2.66M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.03 | 0.00 | -0.02 | -0.01 | -0.02 | -0.01 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 41.55K | 34.76K | 163.00K | 408.07K | 4.10M | 21.43M | 27.42M | 48.80M |
| Cash & ST investments | 35.72K | 28.47K | 160.71K | 405.77K | 217.18K | 2.02M | 466.50K | 3.21M |
| Inventory | -- | -- | -- | -- | 904.10K | 7.02M | 10.21M | 17.06M |
| Total assets | 145.43K | 132.52K | 317.87K | 428.61K | 6.98M | 31.52M | 42.39M | 74.23M |
| Total current liabilities | 368.47K | 1.20M | 1.19M | 287.28K | 7.77M | 8.47M | 21.33M | 26.24M |
| Short-term debt | 30.00K | 457.50K | 195.00K | 145.00K | 6.43M | 6.93M | 15.85M | 12.02M |
| Long-term debt | -- | -- | -- | -- | 469.02K | -- | -- | -- |
| Total liabilities | 368,471.00 | 1,195,782.00 | 1,186,919.00 | 287,281.00 | 9,659,070.00 | 11,797,916.00 | 28,928,110.00 | 36,007,966.00 |
| Total equity | -223.04K | -1.06M | -869.05K | 141.33K | -2.68M | 19.72M | 13.46M | 38.22M |
| Retained earnings | -2.48M | -5.87M | -6.99M | -8.48M | -3.63M | -24.51M | -43.66M | -55.79M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 47.62M | 50.79M | 48.42M | 48.80M | 66.26M | 71.45M |
| Cash & ST investments | 15.87M | 11.38M | 5.68M | 3.21M | 15.98M | 13.65M |
| Inventory | 14.30M | 18.26M | 20.04M | 17.06M | 17.07M | 18.48M |
| Total assets | 63.46M | 69.98M | 69.58M | 74.23M | 90.55M | 96.98M |
| Total current liabilities | 15.00M | 19.61M | 21.19M | 26.24M | 26.05M | 31.89M |
| Short-term debt | 8.05M | 7.33M | 10.41M | 12.02M | 11.73M | 15.32M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 22,902,671.00 | 27,954,902.00 | 29,927,721.00 | 36,007,966.00 | 36,023,476.00 | 43,580,790.00 |
| Total equity | 40.55M | 42.02M | 39.65M | 38.22M | 54.52M | 53.40M |
| Retained earnings | -49.34M | -49.60M | -53.32M | -55.79M | -59.37M | -62.03M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -443.29K | -424.11K | -90.54K | -363.03K | -5.99M | -15.36M | -9.50M | -18.54M |
| Depreciation & amortization | 19.46K | 37.70K | 37.43K | 18.79K | 96.58K | 152.74K | 436.01K | 1.08M |
| Free cash flow | -466.86K | -474.23K | -94.54K | -363.03K | -5.99M | -15.81M | -10.16M | -22.20M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 20.00K | 0 | 194.85K | 557.05K | 0 | 412.06K | -- | -- |
| Ending cash balance | 35.72K | 28.47K | 160.71K | 405.77K | 274.63K | 7.09M | 6.62M | 9.60M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -6.10M | -3.45M | -7.47M | -1.52M | -2.31M | -4.23M |
| Depreciation & amortization | 208.88K | 260.36K | 297.17K | 309.49K | 323.75K | 346.36K |
| Free cash flow | -6.98M | -3.77M | -8.22M | -3.23M | -2.37M | -4.40M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -- | -- | 18.45M | 0 |
| Ending cash balance | 22.08M | 17.61M | 12.04M | 9.60M | 24.01M | 22.67M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -958.97 | -286.52 | -138.00 | -46.94 |
| ROA %i | -293.05 | -2,436.32 | -499.42 | -397.68 | -92.21 | -140.31 | -56.44 | -20.80 |
| ROIC %i | -- | -- | -- | -- | -94.11 | -142.96 | -70.05 | -28.85 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | -- | -- | -- | -347.27 | -88.03 | -16.60 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 0.11 | 0.03 | 0.14 | 1.42 | 0.53 | 2.53 | 1.29 | 1.86 |
| Quick ratioi | 0.10 | 0.02 | 0.14 | 1.41 | 0.35 | 0.69 | 0.36 | 0.82 |
| Debt / assetsi | 20.63 | 345.22 | 61.35 | 33.83 | 118.41 | 29.44 | 42.95 | 19.35 |
| LT debt / equityi | -- | -- | -- | -- | -- | 11.92 | 17.46 | 6.12 |
| Interest coveragei | -- | -170.46 | -1,061.02 | -- | -47.61 | -39.01 | -18.68 | -6.36 |
| Revenue CAGR (3Y) %i | -- | 0.00 | 0.00 | 0.00 | -- | -- | -- | 209.27 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -55.43 | -37.65 | -43.25 | -46.94 | -21.10 | -26.06 |
| ROA %i | -31.73 | -20.51 | -21.57 | -20.80 | -13.02 | -14.89 |
| ROIC %i | -40.00 | -26.46 | -28.21 | -28.85 | -16.81 | -20.50 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -62.48 | -34.81 | -23.05 | -16.60 | -10.11 | -13.40 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 3.18 | 2.59 | 2.29 | 1.86 | 2.54 | 2.24 |
| Quick ratioi | 1.59 | 0.88 | 0.59 | 0.82 | 1.39 | 1.19 |
| Debt / assetsi | 16.47 | 13.99 | 18.23 | 19.35 | 15.26 | 18.43 |
| LT debt / equityi | 5.92 | 5.84 | 5.73 | 6.12 | 3.83 | 4.77 |
| Interest coveragei | -11.89 | -8.46 | -7.80 | -6.36 | -4.84 | -6.16 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Designing, manufacturing and marketing an advanced, next-generation and affordable surgical robotic100.00%
Quote time 2026-10-08 10:00:25 · For reference only, not investment advice and not tailored to your situation.